Evidence is mounting that Omicron’s new sister variant, known as BA.2, is more transmissible than the original strain but at this stage does not appear to be more vaccine-evasive.
The subvariant BA.2 is one of at least three sub-lineages of Omicron, the strain of COVID-19 first spotted in Africa in late November and now dominant around much of the world.
While rare in Australia and most other countries – the virus is found in about 2 per cent of local samples – BA.2 has started to gain a serious foothold in England, India and Denmark, where it has out-competed Omicron and now makes up most viruses sampled.
“That does seem to suggest there is an intrinsic transmissibility advantage,” said Dr Adam Wheatley, who heads a research team studying the immune response to COVID-19 at the University of Melbourne.
Instead, BA.2 is likely to slowly replace Omicron, much as a variant known as D614G quietly replaced the version of the virus that emerged from Wuhan in the middle of 2020.
“Nothing ominous has come out so far. There is no reason to panic,” said Professor Seshadri Vasan, who has been tracking COVID-19’s variants at the CSIRO.
Preliminary data released by Britain’s Health Security Agency earlier this week suggests a two-dose course of vaccine provides essentially no protection against catching either Omicron or BA.2
“The take-home message is: if you are not vaccinated, please go and get that first dose. And if you are double-vaccinated, please go and book a booster,” Professor Vasan said.
Just 34.6 per cent of Australians aged over 12 have had a booster, leaving much of the population vulnerable to Omicron and BA.2.
Evidence from a small number of Omicron infections tracked by British health authorities suggests BA.2’s “secondary attack rate” – the chance of an infected person passing the virus on to someone else in the household – is 13.4 per cent, compared with 10.3 per cent for Omicron.
Scientists are focusing on three main theories to explain Omicron’s emergence.
One possibility: an unknown group of people who have been harbouring an older version of the virus, even as Delta spread around the world. Omicron may have evolved there and then emerged.
Another option: COVID-19 has spilled back from humans into animals, where it has picked up new mutations before jumping back into humans as Omicron. There is good evidence now that a range of animals can be infected with COVID-19, including mink and deer. Denmark culled millions of mink after the animals came down with the virus; late last year US scientists discovered wild deer had become a huge reservoir of COVID-19.
But the most likely option, Dr Wheatley said, was Omicron emerged from a single unlucky individual. This person may have HIV or be being treated with drugs to suppress the immune system. Because their immune system was so weak, they could have been infected with COVID-19 for months.
“You have a situation where you have a virus in a person for a long time, you have an immune system that’s not functioning, and you can get lots of mutations in one person,” said Dr Wheatley.
News
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
